Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (GMAIS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Genervon Biopharmaceuticals, LLC
Sponsor:
Collaborators:
University of California, Los Angeles
Huntington Hospital
Hoag Memorial Hospital Presbyterian
Columbia University
California Pacific Medical Center Research Institute
University Hospital Erlangen
Sarasota Memorial Hospital
University of Louisville
Information provided by (Responsible Party):
Genervon Biopharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT01221246
First received: October 11, 2010
Last updated: August 19, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)